KELLEY MCILVAINE: Open Payments
NPI 1619338688 · PALM HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 37 payments from 13 companies in 2025. Trend: 2023 $1,778 · 2024 $858 · 2025 $955
Food & beverage: $955
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 5 | $307 |
| ABBVIE INC. | 12 | $157 |
| Incyte Corporation | 1 | $126 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| PFIZER INC. | 3 | $52 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $39 |
| Amgen Inc. | 2 | $37 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
Products named: SOFDRA, SKYRIZI, Opzelura, COSENTYX, CIBINQO, Winlevi, OTEZLA, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
